Lupin Introduces Generic Asthma Inhaler Drug ‘Luforbec’ in United Kingdom
The drug making company ‘Lupin Healthcare Limited’, which is a completely owned subsidiary of the company Lupin Limited, has announced that, followed by the approval from the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) in earlier 2021, the company has been successfully launched a new generic asthma inhaler drug known as Luforbec. The […]
Continue Reading